Newcells Biotech strengthens executive and US team with key appointments
Dr Valeria Chichagova appointed as Director of Technology, Dr Colin Brown as Chief Scientific Officer, and Professor Lyle Armstrong as Scientific Advisor New US commercial appointments also announced to meet growing global demand for products and services
Cambridge-based Cofinitive Communications recognised amongst international PR and Communications industry elite
Cambridge-based PR & Comms agency, Cofinitive Communications has been listed in PR Week’s Top 150 PR agency rankings for a third consecutive year.
I do not live with diabetes – should I be monitoring my glucose with CGM?
Nowadays, CGMs are being promoted by various biotech companies and social media influencers as tools for understanding and improving health. Unfortunately, I can see a rise in poorly evidenced health messages. In addition, there are many misleading ads risking people’s health.
The inaugural Cambridge Independent Business Awards are now open for entry
Cambridge Independent are pleased to announce the launch of the inaugural Cambridge Independent Business Awards. A celebration of all business sectors in the Cambridge region, the awards will culminate in a gala event in the magnificent Great Hall at King’s College on 26 September.
Experts launch team effort to help patient Alex
The fifth episode of The Face Doctors on Really, shown at 9pm on Wednesday (12 June) tells the story of a patient who became a prisoner in his own home after his entire nose was lost to cancer.
Nuclera awarded £1.14M Innovate UK funding for development of eProtein Discovery
£790k FASST grant, in collaboration with DeepMirror, and £350k Engineering Biology grant awarded for platform development.
MediMab Biotherapeutics opens bespoke laboratory facilities, created by Kadans Science Partner, at Abingdon Science Park, UK
New CL2 wet lab purpose-built facilities delivered by Kadans Science Partner will support MediMab Biotherapeutics to identify first-in-class immuno-oncology drugs that can actively target a range of advanced and solid tumours Kadans has also completed on Barton Hous
Illumina launches latest chemistry across most popular mid-throughput sequencers, enabling higher quality and greater speed for customers at lower cost
SAN DIEGO - PRNewswire -- Illumina Inc., a global leader in DNA sequencing and array-based technologies, announces it has completed integration of its latest chemistry, XLEAP-SBS™, into all reagents for its NextSeq™ 1000 and NextSeq 2000 next-generation sequencing (NGS) instruments.
o2h Group heralds massive demand for Cambridge Wide Open Day
Attendance levels for the 2024 Cambridge Wide Open Day on Wednesday June 12 are already double the numbers at last year’s inaugural event. o2h Group, which is organising the event, has persuaded some world-class life science and technology companies plus relevant associated organisations to open their doors to visitors.
VALANX Biotech announces promising results in first in-vivo study of novel protein conjugate therapy
Study demonstrates pre-clinical efficacy of lead program VLX101 in treating autoimmune disease
CYPG is recruiting!
Would you like to become a committee member?
Sphere Fluidics launches Cyto-CellectPLUS to accelerate cell line development workflows
Next-generation assay provides a rapid and cost-effective solution to quantify IgG production in single cells
Living with paediatric asthma
A number of different management techniques can help in controlling asthma in children. The aim of these management techniques is to enable the child to have a “normal life”, free of asthma symptoms.
Precision in every layer: celebrating over two decades of 3D printing innovation at IPFL
In the fast-evolving world of 3D printing, staying ahead of the curve means not only keeping pace with current trends but also pioneering new technologies. At IPFL (Industrial Plastic Fabrications Ltd), our unwavering commitment to innovation is evident in our rich history of over 55 years in bespoke plastic manufacturing and a remarkable 21-year journey in additive manufacturing.
Sable&Hawkes deliver campaign graphics and new product illustrations for global biotech
Sable&Hawkes have delivered product and marketing illustrations, icons and infographics for global biopharma and life sciences company Sartorius.
Mursla Bio presents breakthrough liquid biopsy technology for extracellular vesicles in Cell Press
Novel and scalable analysis of extracellular vesicles sub-types detailed in Cell Press’ iScience.
SolasCure selected for Innovate UK Global Incubator Programme in Houston
Programme delivered in partnership with the Texas Medical Centre Programme will support Aurase Wound Gel for future entry into US market, advancing SolasCure’s mission to transform chronic wound care for millions of patients worldwideCam
PhoreMost achieves second milestone in target discovery alliance with Boehringer Ingelheim
Milestone payment follows successful target identification and validation in separate project under same collaboration
DefiniGEN and Atelerix collaborate to ship in vitro cell models internationally without the need for freezing or cryopreservation
Cambridge and Newcastle UK: DefiniGEN Ltd., and Atelerix Ltd., announces they have successfully shipped in vitro liver models from the UK to a top tier pharma customer in the US.
Accelerate@Babraham selects its next set of science superstars!
Cambridge - Six life science start-ups looking to develop products and services to make a positive difference to healthcare have been selected for one of Europe’s top incubators based at the Babraham Research Campus in Cambridge – Accel
Time from EMA approval to CT outcome for first indication vs. AMSR
This post launches a series of infographics focused on pricing and market access trends of rare disease treatments in France.
How ‘The Face Doctors’ help patients face the world
The incredible skills of an Addenbrooke’s prosthetist and three clinicians come into focus in the fourth episode of ‘The Face Doctors’ on Really at 9pm on Wednesday (5 June), also available to stream on discovery+.
Nxera Pharma and PrecisionLife expand strategic R&D partnership into new therapeutic area
Tokyo, Japan, Oxford and Cambridge, UK - Nxera Pharma Co. Ltd and PrecisionLife, the Causal AI precision medicine company, announces the expansion of their strategic R&D partnership into auto-immune disorders with the potential to identify new drug targets for the treatment of complex, chronic conditions.
H.E.L Group extends sales and support with appointment of specialist distributors
Distributors will provide added application specific support for H.E.L’s biotechnology and chemical synthesis product portfolios in the USA, Spain and Portugal.
Impact of medicare price “negotiation” program on small and large molecule medicines
The Inflation Reduction Act (IRA) directs the U.S. federal government to set a “Maximum Fair Price” (MFP) for the medicines with the highest spending in Medicare.